Innovent Biologics, Inc. is a China-based biopharmaceutical company. The Company's main products include PD-1 antibody; bevacizumab (Avastin) biosimilar, IBI-305; rituximab (MabThera/Rituxan) biosimilar, IBI-301; and adalimumab (Humira) biosimilar, IBI-303.

Pharmaceutical

Innovent Biologics

Yu Dechao

Kaiming Wei

Kenneth Kang

Guoqiang Hu

Yong Jun Liu

Astrid Maria Dahl

Gao Changshou

Wang Dongming

Blake Salisbury

Zhang Qian

Xi Hao

Liu Yongjun

Leadership Team

Research and Development

Regulatory and Quality Assurance

Corporate Strategy and Business Development

Marketing and Business Development

Teams at Innovent Biologics

Leadership Team

Research and Development

Regulatory and Quality Assurance

Corporate Strategy and Business Development

Marketing and Business Development